High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment

被引:58
作者
Di Veroli, Giovanni Y. [1 ]
Davies, Mark R.
Zhang, Henggui
Abi-Gerges, Najah
Boyett, Mark R. [1 ]
机构
[1] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2013年 / 304卷 / 01期
关键词
computational modeling; human ether-a-go-go-related gene ion channel; drug-binding kinetics; QT prolongation; Torsades de Pointes arrhythmia; QT INTERVAL PROLONGATION; POTASSIUM CHANNEL; I-KR; VENTRICULAR ARRHYTHMIA; PROARRHYTHMIC RISK; ION CHANNELS; REPOLARIZATION; ELECTROPHYSIOLOGY; CISAPRIDE; BLOCK;
D O I
10.1152/ajpheart.00511.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Di Veroli GY, Davies MR, Zhang H, Abi-Gerges N, Boyett MR. High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment. Am J Physiol Heart Circ Physiol 304: H104-H117, 2013. First published October 26, 2012; doi:10.1152/ajpheart.00511.2012.-The use of computational models to predict drug-induced changes in the action potential (AP) is a promising approach to reduce drug safety attrition but requires a better representation of more complex drug-target interactions to improve the quantitative prediction. The blockade of the human ether-a-go-go-related gene (HERG) channel is a major concern for QT prolongation and Torsade de Pointes risk. We aim to develop quantitative in-silico AP predictions based on a new electrophysiological protocol (suitable for high-throughput HERG screening) and mathematical modeling of ionic currents. Electrophysiological recordings using the IonWorks device were made from HERG channels stably expressed in Chinese hamster ovary cells. A new protocol that delineates inhibition over time was applied to assess dofetilide, cisapride, and almokalant effects. Dynamic effects displayed distinct profiles for these drugs compared with concentration-effects curves. Binding kinetics to specific states were identified using a new HERG Markov model. The model was then modified to represent the canine rapid delayed rectifier K+ current at 37 degrees C and carry out AP predictions. Predictions were compared with a simpler model based on conductance reduction and were found to be much closer to experimental data. Improved sensitivity to concentration and pacing frequency variables was obtained when including binding kinetics. Our new electrophysiological protocol is suitable for high-throughput screening and is able to distinguish drug-binding kinetics. The association of this protocol with our modeling approach indicates that quantitative predictions of AP modulation can be obtained, which is a significant improvement compared with traditional conductance reduction methods.
引用
收藏
页码:H104 / H117
页数:14
相关论文
共 43 条
  • [1] Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential
    Abi-Gerges, Najah
    Valentin, Jean-Pierre
    Pollard, Chris E.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (01) : 77 - 92
  • [2] Assessment of QT liabilities in drug development
    Arrigoni, C.
    Crivori, P.
    [J]. CELL BIOLOGY AND TOXICOLOGY, 2007, 23 (01) : 1 - 13
  • [3] The canine virtual ventricular wall: A platform for dissecting pharmacological effects on propagation and arrhythmogenesis
    Benson, Alan P.
    Aslanidi, Oleg V.
    Zhang, Henggui
    Holden, Arun V.
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2008, 96 (1-3) : 187 - 208
  • [4] Multiscale modelling of drug-induced effects on cardiac electrophysiological activity
    Brennan, T.
    Fink, M.
    Rodriguez, B.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (01) : 62 - 77
  • [5] Antiarrhythmic drugs and cardiac ion channels: mechanisms of action
    Carmeliet, E
    Mubagwa, K
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1998, 70 (01) : 1 - 72
  • [6] Cohen S. D., 1996, Computers in Physics, V10, P138
  • [7] Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (IKr) channel
    Davie, C
    Pierre-Valentin, J
    Pollard, C
    Standen, N
    Mitcheson, J
    Alexander, P
    Thong, B
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (11) : 1302 - 1309
  • [8] An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment
    Davies, M. R.
    Mistry, H. B.
    Hussein, L.
    Pollard, C. E.
    Valentin, J. -P.
    Swinton, J.
    Abi-Gerges, N.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (07): : H1466 - H1480
  • [9] European Medicines Agency, 2011, CPMPICH42302 EUR MED
  • [10] European Medicines Agency, 2011, CHMPICH204 EUR MED A